Management
Charlie Silver
Co-Founder and CEO
Charlie is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.
Dennis Eastburn, PhD
Co-Founder and CSO
Dennis is CSO and co-founder of Mission Bio. Dennis has a track record of technological innovation. As a senior researcher at the University of California, San Francisco (UCSF), Dennis led development of the core IP that is foundational to all of Mission Bio’s products. After starting Mission Bio, he invented the approach for high-throughput single-cell DNA sequencing and applied it to applications in oncology. Dennis has authored over 20 peer-reviewed publications and has secured numerous NIH grants for Mission Bio totaling $3M. Dennis holds a B.S. in molecular biology from the University of Texas at Austin and a Ph.D. in molecular, cellular and developmental biology from the University of Colorado at Boulder. Prior to his work in microfluidics, he completed an NIH funded postdoctoral fellowship studying epithelial cell biology at UCSF.
Keith W. Jones, PhD
Senior Vice President of Product Development
Keith is the Senior Vice President, Development at Mission Bio where he leads a team of Engineers, Biologists, Bioinformaticians, and Data Scientists in the discovery and development of technologies and platforms which enable the analysis of molecular measurements from single cells.
Prior to Mission Bio, Keith worked as a senior technical executive at Affymetrix, Verinata, and Illumina where he led teams innovating and developing complex genetic assays with demonstrated clinical utility.
Keith received Bachelor of Science degrees in both Biological Sciences and Chemistry from the University of California, Irvine. He received his Ph.D. in Pharmacology from Stanford University.
Pat Brooks
Senior Vice President of Sales and Sales Operations
Pat is Senior Vice President of Sales and Sales Operations and brings more than 30 years of international sales experience within the life sciences industry to Mission Bio. He leads the global deployment of the Tapestri platform worldwide. Prior to joining Mission Bio, Pat spent three years as Vice President of Global Sales and Development at Cellular Dynamics International. His sales leadership experience also includes Vice President roles at Ion Torrent, Pacific Biosciences and Affymetrix. Pat holds both Master of Science and Bachelor of Science degrees from the University of Iowa.
Rebecca M. Galler
Senior Vice President of Marketing
Rebecca is Senior Vice President of Marketing and comes to Mission Bio with over 20 years of life sciences and healthcare experience. As SVP of Marketing, Rebecca oversees the corporate and brand development and marketing of Mission Bio and Tapestri. Rebecca has spearheaded strategic marketing for venture-backed companies Qventus and Castlight Health. She has held leadership roles at Sirna Therapeutics, INVESCO Funds Group, and Preferred Global Health. Rebecca holds an M.B.A. from Columbia University and a B.A. from Barnard College.
Adam Sciambi, PhD
Co-Founder and Director of Engineeering
Adam is a co-founder of Mission Bio and heads cartridge and instrument development as Director of Engineering. He was first initiated into microfluidics when he joined Adam Abate’s UCSF lab after receiving a PhD in Applied Physics from Stanford. As a postdoc at UCSF, he took the fabrication and engineering skillset learned from condensed matter physics and applied it to droplet manipulation, ultimately codeveloping the technology that became the core of Mission Bio. He continues to be interested in tackling complex, interdisciplinary problems with physics.
Anup Parikh
Senior Director of Software Strategy
Anup is Senior Director of Software Strategy at Mission Bio. Anup has been following his passion to build novel solutions that leverage software and automation to improve health. Previously, he was part of product management at 10x Genomics and Thermo Fisher Scientific, developing novel technologies for targeted sequencing applications. Anup received his Ph.D. from Baylor College of Medicine in Structural and Computational Biology.
Hannah Viernes
Senior Director of Product Management
Hannah is Senior Director of Product Management and brings deep experience in developing product strategy, roadmap, and requirements with cross-functional teams and in launching successful life sciences products. She previously led the NGS market development team at the Clinical Sequencing Division for Thermo Fisher Scientific, and served various marketing and product management roles at Ion Torrent, Life Technologies and Affymetrix. Hannah received her BS in Cell and Molecular Biology from University of Washington.
William Oldham
Associate Director of Manufacturing
William J Oldham is Associate Director of Manufacturing. He has extensive experience delivering value and operational excellence to startups and large companies. Prior to Mission Bio, William served at Ion torrent, Twist BioScience and Exelixis. William has an MS in synthetic organic chemistry and a BS in Biochemistry from the University of Oregon.
Board of Directors
Adam Abate, PhD
Board of Director
Adam R. Abate, PhD is a physicist and bioengineer with a research focus on developing new tools for high-throughput biology. He is a co-inventor of droplet-based genomic cytometry and co-founder of Mission Bio. He is a faculty member at UCSF and part of the California Institute for Quantitative Biosciences (QB3) and a recent winner of the NSF CAREER and NIH New Innovator Awards. His lab continues to develop new technologies for biomedical research, protein engineering, and synthetic biology.
Bill Hyun, PhD
Board of Director
William Hyun, MS, PhD is the Director of the Laboratory for Advanced Cytometry at the University of California, San Francisco (UCSF). He leverages over 25 years of translational and clinical research experience into founder, investor and advisor roles for several biotechnology companies and life science investment groups. At UCSF, he helped build the world’s largest academic cytometry facility and continues to design and build next generation cell sorters, commercial flow cytometers and confocal microscopes.
Brock Siegel, PhD
Board of Director
Brock Siegel, PhD, is an investor and advisor in seed-stage life science investment groups including BioInflexion Point, Life Science Angels, NEW Capital Fund LP, and QB3 Mission Bay Capital Fund. He serves on the Board of Directors of Rapid Diagnostek Inc and the Addario Lung Cancer Medical Institute, and on the Advisory Boards of Ruubix Diagnostics Inc and Moleculo Sequencing Inc. Brock has been a senior executive with Millipore, BioSearch, Applied Biosystems, Solexa, Illumina, Complete Genomics and Moleculo. Academically trained in bio-organic chemistry, he holds a BS from Syracuse University, a PhD in Chemistry from the University of Illinois, completed his post-doctoral work at Columbia University, and is a former Professor at the University of Minnesota.
Maneesh Jain, PhD
Board of Director
Maneesh is an experienced entrepreneur and CEO who has successfully commercialized multiple life science technologies over the past 20 years, spanning early/founding roles in five successful startups, most recently as CEO of Cirina Inc. Maneesh’s startups include ParAllele (AFFX: 2005), Auriphex (ILMN: 2009), Ion Torrent (LIFE: 2010), Butterfly (FDA: 2017), and Cirina (GRAIL: 2017), totaling over $1.5B in exits. Maneesh has served as an executive advisor or independent board member to several life science companies including Cellular Research (BD: 2015), Counsyl, Inscopix, Invitae (NYSE: 2015), Magarray, Mission Bio and NextBio (ILMN: 2013). Maneesh focuses on companies developing innovative products/services in the genomics, medical imaging and molecular diagnostic markets. Maneesh is also an avid windsurfer.
Paul Billings, MD, PhD
Board of Director
Paul R. Billings MD, PhD, FACP, FACMG is a physician, researcher in immunology and biomedicine, corporate executive and entrepreneur. He currently serves as a consultant to several public biotechnology companies and as a director in the for-profit and non-for-profit sectors. His interests are in enabling the development of global precision medicine through basic research and innovation.
Ursheet Parikh
Board of Director
Ursheet is a proven repeat entrepreneur and executive who brings 15 years of product and leadership experience to the investment team at Mayfield. He focuses on innovation that is redefining the application and infrastructure stacks in cloud, mobile, enterprise technologies, genomics and digital health.
Prior to joining Mayfield, he was a co-founder & CEO of StorSimple and then a GM at Microsoft. StorSimple was the leading cloud-integrated storage company that was acquired by Microsoft. StorSimple was the largest acquisition among the first generation of cloud IaaS/PaaS technology companies and has been highlighted by Microsoft as one of its most successful acquisitions. At Cisco he took the WAN acceleration product line from concept to $100M/quarter and market leadership in 2008. Ursheet also worked at numerous startups including Andiamo Systems which was acquired by Cisco.
Ursheet holds an MBA from the Wharton School and a Bachelors in Computer Science from the Indian Institute of Technology in Mumbai, from which he received the Young Alumni Achiever award in 2015.
Charlie Silver
Co-Founder and CEO
Charlie is CEO and co-founder of Mission Bio where he leads a team dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. Charlie has dedicated his career to commercializing next-generation hardware technology and scientific instrumentation at emerging ventures in healthcare and semiconductor. Prior to Mission Bio, he led engineering at Novelx (acquired by Agilent) and then served in R&D and marketing at Agilent. Charlie received a joint MBA from UC Berkeley and Columbia University, an MS in physics from UW Madison, and a BA in physics from Columbia University.